[Clinical experience in the diagnosis and therapy of plasmacytoma (author's transl)]

Wien Med Wochenschr. 1979 Feb 28;129(4):101-6.
[Article in German]

Abstract

8 patients with plasmocytomas were treated with Endoxan and compared with 5 patients without any considerable treatment. Diagnosis, therapy and prognosis of plasmocytoma are discussed. Particularly mentioned are 3 patients with secondary tumours during cytostatic treatment, a plasmocytoma without paraprotein, a tumorous plasmocytoma with double paraproteinemia and a gammopathia with further development into a plasmocytoma 10 years later.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Aged
  • Alkylating Agents / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypergammaglobulinemia / complications
  • Immunoglobulin A
  • Immunoglobulin D
  • Immunoglobulin G
  • Immunoglobulin M
  • Male
  • Melphalan / therapeutic use
  • Middle Aged
  • Plasmacytoma / complications
  • Plasmacytoma / diagnosis*
  • Plasmacytoma / drug therapy
  • Prognosis

Substances

  • Alkylating Agents
  • Immunoglobulin A
  • Immunoglobulin D
  • Immunoglobulin G
  • Immunoglobulin M
  • Cyclophosphamide
  • Melphalan